Table 1.

Demographics of human cases used to generate experimental lysate

	Age at onset	Age at death	Pathology diagnosis	Braak stage	Thal phase	CERAD score
Control 1	N/A	82	Cerebrovascular arteriolosclerosis	I/II	2	C1
Control 2	N/A	52	No neuropathology diagnosis	I/II	2	C1
MSA 1	58	67	MSA-C/OPCA	–	0	C0
MSA 2	68	71	MSA-P/SND	–	2	C1

MSA-C multiple system atrophy-cerebellar, OPCA olivo-ponto-cerebellar atrophy, MSA-P multiple system atrophy-parkinsonism, SND striatonigral degeneration